Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-28 Sale |
2021-03-04 5:00 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
5,344 | $62.93 | $336,297 | 233,094 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 4:52 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
37,851 | $38.16 | $1,444,206 | 306,521 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-13 5:43 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $40 | $65,960 | 145,917 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 4:57 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
20,000 | $26.35 | $527,037 | 85,389 (Direct) |
View |
| 2020-05-22 Sale |
2020-05-26 5:58 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
7,500 | $30 | $225,000 | 147,566 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-28 Exercise |
2021-03-04 5:00 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
13,195 | $0 | 233,094 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 5:00 pm |
N/A 2031-03-01 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
40,800 | $0 | 233,094 (Direct) |
View |
| 2020-12-28 Exercise |
2021-03-04 5:00 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
13,195 | $0.6 | 233,094 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:52 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
37,851 | $0 | 306,521 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:52 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
36,348 | $0.6 | 306,521 (Direct) |
View |
| 2020-10-19 Exercise |
2020-10-20 4:52 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,503 | $2.19 | 306,521 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-13 5:43 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $0 | 145,917 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-13 5:43 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $0.6 | 145,917 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:57 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
20,000 | $0 | 85,389 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:57 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
20,000 | $2.19 | 85,389 (Direct) |
View |
| 2020-05-22 Exercise |
2020-05-26 5:58 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
7,500 | $0 | 147,566 (Direct) |
View |
| 2020-05-22 Exercise |
2020-05-26 5:58 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
7,500 | $0.6 | 147,566 (Direct) |
View |